Literature DB >> 26581171

Exploring preferred amino acid mutations in cancer genes: Applications to identify potential drug targets.

P Anoosha1, R Sakthivel1, M Michael Gromiha2.   

Abstract

Somatic mutations developed with missense, silent, insertions and deletions have varying effects on the resulting protein and are one of the important reasons for cancer development. In this study, we have systematically analysed the effect of these mutations at protein level in 41 different cancer types from COSMIC database on different perspectives: (i) Preference of residues at the mutant positions, (ii) probability of substitutions, (iii) influence of neighbouring residues in driver and passenger mutations, (iv) distribution of driver and passenger mutations around hotspot site in five typical genes and (v) distribution of silent and missense substitutions. We observed that R→H substitution is dominant in drivers followed by R→Q and R→C whereas E→K has the highest preference in passenger mutations. A set of 17 mutations including R→Y, W→A and V→R are specific to driver mutations and 31 preferred substitutions are observed only in passenger mutations. These frequencies of driver mutations vary across different cancer types and are selective to specific tissues. Further, driver missense mutations are mainly surrounded with silent driver mutations whereas the passenger missense mutations are surrounded with silent passenger mutations. This study reveals the variation of mutations at protein level in different cancer types and their preferences in cancer genes and provides new insights for understanding cancer mutations and drug development.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Driver mutation; Mutation frequency; Passenger; Substitution matrix

Mesh:

Substances:

Year:  2015        PMID: 26581171     DOI: 10.1016/j.bbadis.2015.11.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Cancer-associated arginine-to-histidine mutations confer a gain in pH sensing to mutant proteins.

Authors:  Katharine A White; Diego Garrido Ruiz; Zachary A Szpiech; Nicolas B Strauli; Ryan D Hernandez; Matthew P Jacobson; Diane L Barber
Journal:  Sci Signal       Date:  2017-09-05       Impact factor: 8.192

2.  The structure-based cancer-related single amino acid variation prediction.

Authors:  Jia-Jun Liu; Chin-Sheng Yu; Hsiao-Wei Wu; Yu-Jen Chang; Chih-Peng Lin; Chih-Hao Lu
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

3.  Systematic analysis of somatic mutations driving cancer: uncovering functional protein regions in disease development.

Authors:  Bálint Mészáros; András Zeke; Attila Reményi; István Simon; Zsuzsanna Dosztányi
Journal:  Biol Direct       Date:  2016-05-05       Impact factor: 4.540

4.  Prominent features of the amino acid mutation landscape in cancer.

Authors:  Zachary A Szpiech; Nicolas B Strauli; Katharine A White; Diego Garrido Ruiz; Matthew P Jacobson; Diane L Barber; Ryan D Hernandez
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

5.  Toward an integrated map of genetic interactions in cancer cells.

Authors:  Benedikt Rauscher; Florian Heigwer; Luisa Henkel; Thomas Hielscher; Oksana Voloshanenko; Michael Boutros
Journal:  Mol Syst Biol       Date:  2018-02-21       Impact factor: 11.429

6.  Single Synonymous Mutations in KRAS Cause Transformed Phenotypes in NIH3T3 Cells.

Authors:  Andrew M Waters; Rachel Bagni; Franklin Portugal; James L Hartley
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

7.  Identifying Cancer-Relevant Mutations in the DLC START Domain Using Evolutionary and Structure-Function Analyses.

Authors:  Ashton S Holub; Renee A Bouley; Ruben C Petreaca; Aman Y Husbands
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

8.  A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database.

Authors:  Amrit L Pappula; Shayaan Rasheed; Golrokh Mirzaei; Ruben C Petreaca; Renee A Bouley
Journal:  Cancers (Basel)       Date:  2021-08-26       Impact factor: 6.639

9.  Arginine Depletion in Human Cancers.

Authors:  Devi D Nelakurti; Tiffany Rossetti; Aman Y Husbands; Ruben C Petreaca
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.